<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30061414</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>02</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1091-6490</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>115</Volume>                    <Issue>33</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>08</Month>                        <Day>14</Day>                    </PubDate>                </JournalIssue>                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>            </Journal>            <ArticleTitle>Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.</ArticleTitle>            <Pagination>                <MedlinePgn>E7786-E7794</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1805020115</ELocationID>            <Abstract>                <AbstractText>The action of the collagen binding receptor tyrosine kinase (RTK) discoidin domain receptor 2 (DDR2) in both tumor and tumor stromal cells has been established as critical for breast cancer metastasis. Small molecule inhibitors that target the extracellular domain of RTKs are rare, as they have classically been regarded as too small to block binding with large polypeptide ligands. Here, we report the identification and characterization of a selective, extracellularly acting small molecule inhibitor (WRG-28) of DDR2 that uniquely inhibits receptor-ligand interactions via allosteric modulation of the receptor. By targeting DDR2, WRG-28 inhibits tumor invasion and migration, as well as tumor-supporting roles of the stroma, and inhibits metastatic breast tumor cell colonization in the lungs. These findings represent an approach to inhibiting tumor-stromal interactions and support the development of allosteric inhibitors of DDR2, such as WRG-28, as a promising approach to antimetastasis treatment.</AbstractText>                <CopyrightInformation>Copyright Â© 2018 the Author(s). Published by PNAS.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Grither</LastName>                    <ForeName>Whitney R</ForeName>                    <Initials>WR</Initials>                    <AffiliationInfo>                        <Affiliation>Integrating Communication within the Cancer Environmental Institute, Washington University, St. Louis, MO 63110.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Biochemistry and Biophysics, Washington University, St. Louis, MO 63110.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Longmore</LastName>                    <ForeName>Gregory D</ForeName>                    <Initials>GD</Initials>                    <Identifier Source="ORCID">0000-0001-7568-8151</Identifier>                    <AffiliationInfo>                        <Affiliation>Integrating Communication within the Cancer Environmental Institute, Washington University, St. Louis, MO 63110; glongmore@wustl.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, Washington University, St. Louis, MO 63110.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Cell Biology and Physiology, Washington University, St. Louis, MO 63110.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>R01 CA196205</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>T32 GM007200</GrantID>                    <Acronym>GM</Acronym>                    <Agency>NIGMS NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>U54 CA210173</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>            <NlmUniqueID>7505876</NlmUniqueID>            <ISSNLinking>0027-8424</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D009363">Neoplasm Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="C000603239">DDR2 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="D000070820">Discoidin Domain Receptor 2</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Discov. 2011 Jun;1(1):78-89</RefSource>                <PMID Version="1">22328973</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann N Y Acad Sci. 1960 Oct 5;89:348-60</RefSource>                <PMID Version="1">13735270</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Matrix Biol. 2011 Jan;30(1):16-26</RefSource>                <PMID Version="1">21044884</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 2014 Sep;1842(9):1350-63</RefSource>                <PMID Version="1">24787381</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Pharm Bull. 2009 Jan;32(1):136-41</RefSource>                <PMID Version="1">19122296</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2013 Apr 15;23(4):489-501</RefSource>                <PMID Version="1">23597563</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochemistry. 2002 Sep 17;41(37):11091-8</RefSource>                <PMID Version="1">12220173</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Structure. 2009 Dec 9;17(12):1573-1581</RefSource>                <PMID Version="1">20004161</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2012 May 15;72(10):2473-80</RefSource>                <PMID Version="1">22414581</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Struct Biol. 2013 Sep;183(3):495-500</RefSource>                <PMID Version="1">23810922</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2013 Mar 15;288(11):7430-7</RefSource>                <PMID Version="1">23335507</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biol Ther. 2014 May;15(5):612-22</RefSource>                <PMID Version="1">24556606</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pharmacol Exp Ther. 2005 Dec;315(3):971-9</RefSource>                <PMID Version="1">16002463</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2013 Apr 15;23(4):477-88</RefSource>                <PMID Version="1">23597562</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Pharmacol Toxicol. 2014;54:165-84</RefSource>                <PMID Version="1">24111540</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Ther. 2016 Oct;24(10):1734-1744</RefSource>                <PMID Version="1">27350126</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Biol. 2011 May 6;408(3):568-84</RefSource>                <PMID Version="1">21376729</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer. 2010 Apr 12;9:75</RefSource>                <PMID Version="1">20385023</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 1997 Dec;1(1):25-34</RefSource>                <PMID Version="1">9659900</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Rep. 2016 Jun 14;15(11):2510-23</RefSource>                <PMID Version="1">27264173</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Cell Biol. 2013 Jun;15(6):677-87</RefSource>                <PMID Version="1">23644467</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Metastasis Rev. 2012 Jun;31(1-2):295-321</RefSource>                <PMID Version="1">22366781</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2014 Mar 17;25(3):282-303</RefSource>                <PMID Version="1">24651011</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Commun Signal. 2011 Oct 28;9(1):23</RefSource>                <PMID Version="1">22035226</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Cell Cardiol. 2016 Jan;90:59-69</RefSource>                <PMID Version="1">26674152</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Matrix Biol. 2014 Feb;34:185-92</RefSource>                <PMID Version="1">24361528</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Angew Chem Int Ed Engl. 2003 Jun 6;42(22):2462-81</RefSource>                <PMID Version="1">12800163</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO J. 2012 Jan 4;31(1):29-43</RefSource>                <PMID Version="1">21952048</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2008 Mar 14;283(11):6861-8</RefSource>                <PMID Version="1">18201965</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2014 Feb;13(2):475-82</RefSource>                <PMID Version="1">24296828</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2016 Jul 7;535(7610):148-52</RefSource>                <PMID Version="1">27362227</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Feb;150(1):9-18</RefSource>                <PMID Version="1">25667101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2010 Dec 14;18(6):630-40</RefSource>                <PMID Version="1">21130043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Comput Chem. 2010 Jan 30;31(2):455-61</RefSource>                <PMID Version="1">19499576</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Structure. 2012 Apr 4;20(4):688-97</RefSource>                <PMID Version="1">22483115</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2004 May;4(5):361-70</RefSource>                <PMID Version="1">15122207</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 2014 May 22;57(10):4252-62</RefSource>                <PMID Version="1">24754677</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2013 Jul 17;105(14):1043-9</RefSource>                <PMID Version="1">23744877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Rep. 2017 Feb 14;18(7):1774-1790</RefSource>                <PMID Version="1">28199848</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Drug Discov. 2002 Mar;1(3):198-210</RefSource>                <PMID Version="1">12120504</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2015 Sep 11;34:101</RefSource>                <PMID Version="1">26362312</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 2016 Nov;186(11):3000-3010</RefSource>                <PMID Version="1">27640147</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2006 Aug 11;281(32):22744-51</RefSource>                <PMID Version="1">16774916</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 1997 Dec;1(1):13-23</RefSource>                <PMID Version="1">9659899</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Head Neck. 2008 Apr;30(4):427-36</RefSource>                <PMID Version="1">18023033</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Biol. 2009 Jan 20;7(1):e17</RefSource>                <PMID Version="1">19166270</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2005 Nov 11;310(5750):1022-5</RefSource>                <PMID Version="1">16284179</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 2003 Nov;163(5):2113-26</RefSource>                <PMID Version="1">14578209</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 2011 Mar;178(3):1221-32</RefSource>                <PMID Version="1">21356373</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2016 Aug 25;166(5):1084-1102</RefSource>                <PMID Version="1">27565340</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2014 Nov 1;74(21):6330-40</RefSource>                <PMID Version="1">25164016</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2003 May 9;278(19):16761-9</RefSource>                <PMID Version="1">12611880</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Electrophoresis. 2009 Jun;30 Suppl 1:S162-73</RefSource>                <PMID Version="1">19517507</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2012 Mar 20;21(3):309-22</RefSource>                <PMID Version="1">22439926</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000494" MajorTopicYN="N">Allosteric Regulation</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000070820" MajorTopicYN="N">Discoidin Domain Receptor 2</DescriptorName>                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009363" MajorTopicYN="N">Neoplasm Proteins</DescriptorName>                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D059016" MajorTopicYN="N">Tumor Microenvironment</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">DDR2</Keyword>            <Keyword MajorTopicYN="Y">allosteric inhibition</Keyword>            <Keyword MajorTopicYN="Y">metastasis</Keyword>        </KeywordList>        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30061414</ArticleId>            <ArticleId IdType="pii">1805020115</ArticleId>            <ArticleId IdType="doi">10.1073/pnas.1805020115</ArticleId>            <ArticleId IdType="pmc">PMC6099886</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>